AI coach joins fight against diabetes in new online lifestyle trial
NCT ID NCT07661381
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a personalized online lifestyle program, with or without a virtual AI coach, can help people with type 2 diabetes improve their blood sugar control. 160 adults will use continuous glucose monitors and attend online group sessions over 12 months, with follow-ups up to 24 months. The main goal is to see if HbA1c levels drop, along with other health measures like weight and blood pressure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Lifestyle program with virtual AI lifestyle coach and continuous glucose monitoring
What this could lead to
If successful, this could offer an effective, remote way to help people with type 2 diabetes better manage their blood sugar and overall health without needing extra medication.
What could go wrong
This is a feasibility study, not a large late-stage trial. The AI coach is new, and results may not apply to everyone. Lifestyle changes can be hard to maintain long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES TYPE 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Twente
Enschede, Overijssel, 7500 AE, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact